Guangdong Baolight Medical Technology Co., Ltd. announced a trading suspension for its stock and convertible bonds due to its controlling shareholder planning a change of control. The suspension, effective August 3, 2026, is expected to last no more than two trading days. The company aims to protect investor interests and prevent significant market impact during this uncertain period.
Summary generated by AI · Always verify with source document
Securities Code: 300246
Bond Code: 123065
Securities Abbreviation: Baolight
Bond Abbreviation: Baolight Convertible Bond
Announcement Number: 2026-048
Guangdong Baolight Medical Technology Co., Ltd.
Announcement on Suspension of Trading Due to Planned Change of Control
The Company and all members of its Board of Directors guarantee the content of the information disclosure is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.